drugset / Trial / NCT03242317
A Prospective Study to Evaluate the Raindrop Near Vision Inlay With Mitomycin C
NaSingle-groupOpen-labelPrevention
Summary
The objective of this study is to evaluate the Raindrop® Near Vision Inlay for the improvement of near vision in presbyopes treated with low dose, short duration Mitomycin C (MMC) during surgery and an extended low dose steroid regimen after surgery.
Timeline
- Start
- 2017-06-16
- Primary completion
- 2020-09-01
- Completion
- 2020-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Mitomycin C | Other / unclassified | 0.2 mg/ml | — |